共 34 条
[1]
Barbera J.A., Blanco I., Pulmonary hypertension in patients with chronic obstructive pulmonary disease: Advances in pathophysiology and management, Drugs, 69, pp. 1153-1171, (2009)
[2]
Barbera J.A., Riverola A., Roca J., Ramirez J., Wagner P.D., Ros D., Et al., Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease, Am. J. Respir. Crit. Care Med, 149, pp. 423-429, (1994)
[3]
Barbera J.A., Peinado V.I., Santos S., Ramirez J., Roca J., Rodriguez-Roisin R., Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers, Am. J. Respir. Crit. Care Med, 164, pp. 709-713, (2001)
[4]
Barbera J.A., Peinado V.I., Santos S., Pulmonary hypertension in chronic obstructive pulmonary disease, Eur. Respir. J, 21, pp. 892-905, (2003)
[5]
Budhiraja R., Tuder R.M., Hassoun P.M., Endothelial dysfunction in pulmonary hypertension, Circulation, 109, pp. 159-165, (2004)
[6]
Dinh-Xuan A.T., Higenbottam T.W., Clelland C.A., Pepke-Zaba J., Cremona G., Butt A.Y., Et al., Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease, N. Engl. J. Med, 324, pp. 1539-1547, (1991)
[7]
Duong-Quy S., Dao P., Hua-Huy T., Guilluy C., Pacaud P., Dinh-Xuan A.T., Increased Rho-kinase expression and activity and pulmonary endothelial dysfunction in smokers with normal lung function, Eur. Respir. J, 37, pp. 349-355, (2011)
[8]
Duong-Quy S., Bei Y., Liu Z., Dinh-Xuan A.T., Role of Rho-kinase and its inhibitors in pulmonary hypertension, Pharmacol. Ther., 137, pp. 352-364, (2013)
[9]
Frost F.J., Petersen H., Tollestrup K., Skipper B., Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins, Chest, 131, pp. 1006-1012, (2007)
[10]
Hidaka T., Hata T., Soga J., Fujii Y., Idei N., Fujimura N., Et al., Increased leukocyte Rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokers, Hypertens. Res., 33, pp. 354-359, (2010)

